Dr. Albon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1221 Hospital Dr
Charlottesville, VA 22908Phone+1 434-924-5219Fax+1 434-244-7509
Summary
- Dana Albon, MD, based in Charlottesville, VA, is an Associate Professor at the University of Virginia and specializes in pulmonology with subspecialties in bronchiectasis and cystic fibrosis. She completed a pulmonary and critical care fellowship at Wake Forest University and a lung transplant pulmonology and advanced lung disease at Duke University Hospital and gained experience in transplant pulmonology. She worked as an instructor at Duke University Hospital from 2012 to 2013. Dr. Albon has contributed to research, published several papers on cystic fibrosis, and has been involved in clinical trials. She received the CMS Meaningful Use Stage 1 Certification from Epic Systems Corporation in 2013.
Education & Training
- Duke University HospitalFellowship, Lung Transplant Pulmonology and Advanced Lung Disease, 2011 - 2012
- Wake Forest University Baptist Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2011
- Cone HealthResidency, Internal Medicine, 2005 - 2008
- Iuliu Hatieganu University of Medicine and PharmacyClass of 2001
Certifications & Licensure
- VA State Medical License 2014 - 2026
- NC State Medical License 2008 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Feasibility of a Goal-based Agenda Setting Intervention Start of enrollment: 2021 Jan 14
Publications & Presentations
PubMed
- Reconsidering the Diagnosis: Abnormal Sweat Chloride Tests in Non-CF Bronchiectasis.Reyna L Huang, Matthew T Snyder, Nuzhat Fahmida, Dana P Albon
Pediatric Pulmonology. 2025-01-07 - Impact of Elexacaftor/Tezacaftor/Ivacaftor on Hemoglobin Levels and Mean Corpuscular Volume in Adults With Cystic Fibrosis.Amber James, Z Galvin Li, Magdalene Kwarteng, Rhonda List, Dana Albon
Pediatric Pulmonology. 2025-01-01 - Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk population.Lindsay Somerville, Larry Borish, Imre Noth, Dana Albon
Therapeutic Advances in Respiratory Disease. 2024-11-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: